AR246186A1 - Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica. - Google Patents

Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.

Info

Publication number
AR246186A1
AR246186A1 AR89315479A AR31547989A AR246186A1 AR 246186 A1 AR246186 A1 AR 246186A1 AR 89315479 A AR89315479 A AR 89315479A AR 31547989 A AR31547989 A AR 31547989A AR 246186 A1 AR246186 A1 AR 246186A1
Authority
AR
Argentina
Prior art keywords
estradiol
procedure
manufacturing
aives
pressure sensitive
Prior art date
Application number
AR89315479A
Other languages
English (en)
Original Assignee
Beta Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3478739&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR246186(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beta Pharm Co filed Critical Beta Pharm Co
Priority to AR89315479A priority Critical patent/AR246186A1/es
Priority to DE69009697T priority patent/DE69009697T3/de
Priority to ES90312435T priority patent/ES2057442T5/es
Priority to DK90312435T priority patent/DK0430491T4/da
Priority to AT90312435T priority patent/ATE106753T1/de
Priority to EP90312435A priority patent/EP0430491B2/en
Priority to MX023357A priority patent/MX171907B/es
Priority to BR909005908A priority patent/BR9005908A/pt
Priority to JP2312573A priority patent/JPH03227920A/ja
Publication of AR246186A1 publication Critical patent/AR246186A1/es
Application granted granted Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO PARA FABRICAR EL DISPOSITIVO DE ADMINISTRACION DE ESTRADIOL POR VIA TRANSDERMAL, QUE COMPRENDE: A) DEPOSITAR UN REVESTIMIENTO ADHESIVO SENSIBLE A LA PRESION, SOBRE UNA PELICULA FLEXIBLE, RECUBIERTA CON SILICONA, QUE COMPRENDE: A) DEPOSITAR UN REVESTIMIENTO ADHESIVO SENSIBLE A LA PRESION, SOBRE UNA PELICULA FLEXIBLE, RECUBIERTA CON SILICONA, QUE COMPRENDE: UNA COMPOSICION ADHESIVA SENSIBLE A LA PRESION DERMATOLOGICAMENTE ACEPTABLE, EN LA QUE SE ENCUENTRA HOMOGENEAMENTE DISTRIBUIDO ESTRADIOL, COMO AGENTE FARMACOLOGICAMENTE ACTIVO Y UN COMPONENTE BINARIO INCREMENTADOR DE LA VELOCIDAD DE PERMEACION DEL ESTRADIOL, QUE TIENE DE 1 A 20% DE ACIDOS GRASOS NO SATURADOS (C12-C18), O SUS ESTERES DE ALQUILO Y DE 5 A 30% DE GLICERINA O ALQUILEN (C3-C6) 1,2- DIOLES, CORRESPONDIENDO LOS VALORES A PARTES EN PESO POR CADA 100 PARTES DE RECUBRIMIENTO ADHESIVO, ESTANDO EL CONTENIDO DE ESTRADIOL EN EXCESO SOBRE LA CONCENTRACION DE SATURACION EN LA COMPOSICION ADHESIVA:B) CUBRIR EL REVESTI MIENTO CON UNA LAMINA FLEXIBLE; Y C) CORTAR LA ESTRUCTURA DE CARGAS SUPERPUESTAS ASI FORMADA, EN PORCIONES DE FORMA Y DIMENSIONES DETERMINADAS.
AR89315479A 1989-11-17 1989-11-17 Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica. AR246186A1 (es)

Priority Applications (9)

Application Number Priority Date Filing Date Title
AR89315479A AR246186A1 (es) 1989-11-17 1989-11-17 Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
AT90312435T ATE106753T1 (de) 1989-11-17 1990-11-14 Gegenstand für die transdermale applikation von estradiol und verfahren zur herstellung eines solchen gegenstandes.
ES90312435T ES2057442T5 (es) 1989-11-17 1990-11-14 Dispositivo para el suministro de estradiol por via transdermal y proceso de fabricacion de dicho dispositivo.
DK90312435T DK0430491T4 (da) 1989-11-17 1990-11-14 Transdermalt afgivelsesorgan for estradiol og fremgangsmåde til fremstilling af organet
DE69009697T DE69009697T3 (de) 1989-11-17 1990-11-14 Gegenstand für die transdermale Applikation von Estradiol und Verfahren zur Herstellung eines solchen Gegenstandes.
EP90312435A EP0430491B2 (en) 1989-11-17 1990-11-14 Transdermal delivery device for estradiol and process for manufacturing said device
MX023357A MX171907B (es) 1989-11-17 1990-11-16 Dispositivo para administrar estradiol por via transdermica y procedimiento para fibricar dicho dispositivo
BR909005908A BR9005908A (pt) 1989-11-17 1990-11-16 Aparelho transdermico de distribuicao para o estradiol e processo para fabricacao do aparelho
JP2312573A JPH03227920A (ja) 1989-11-17 1990-11-17 エストラジオールのための経皮デリバリー装置および該装置の製法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AR89315479A AR246186A1 (es) 1989-11-17 1989-11-17 Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.

Publications (1)

Publication Number Publication Date
AR246186A1 true AR246186A1 (es) 1994-07-29

Family

ID=3478739

Family Applications (1)

Application Number Title Priority Date Filing Date
AR89315479A AR246186A1 (es) 1989-11-17 1989-11-17 Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.

Country Status (9)

Country Link
EP (1) EP0430491B2 (es)
JP (1) JPH03227920A (es)
AR (1) AR246186A1 (es)
AT (1) ATE106753T1 (es)
BR (1) BR9005908A (es)
DE (1) DE69009697T3 (es)
DK (1) DK0430491T4 (es)
ES (1) ES2057442T5 (es)
MX (1) MX171907B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
JP2960832B2 (ja) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト エストラジオールの投与システム
DE4237453C1 (es) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
GR1002079B (en) * 1994-07-26 1995-12-05 Lavipharm A E System of a special structure and composition for the rapid transdermal administration of oestrogens.
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
GB9720470D0 (en) 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
DE19815060A1 (de) * 1998-04-03 1999-10-14 Jenapharm Gmbh Pharmazeutische Präparate zur Therapie von Nebenwirkungen während und/oder nach einer GnRHa-Therapie
SE9801704D0 (sv) 1998-05-14 1998-05-14 Bioglan Ab Biologically active composition
DE10003397A1 (de) * 2000-01-27 2001-08-09 Hartmann Paul Ag Polyelektrolyt-Feststoffsystem, Verfahren zur Herstellung desselben sowie Wundverband
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4764381A (en) * 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
US4908389A (en) * 1986-08-27 1990-03-13 Warner-Lambert Company Penetration enhancement system
US4994267A (en) † 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
WO1990006120A1 (en) * 1988-12-01 1990-06-14 Schering Corporation Compositions for transdermal delivery of estradiol

Also Published As

Publication number Publication date
DE69009697T2 (de) 1994-12-22
DE69009697D1 (de) 1994-07-14
DK0430491T4 (da) 2001-01-02
ATE106753T1 (de) 1994-06-15
ES2057442T3 (es) 1994-10-16
EP0430491A2 (en) 1991-06-05
ES2057442T5 (es) 2001-02-16
JPH03227920A (ja) 1991-10-08
DE69009697T3 (de) 2001-02-22
MX171907B (es) 1993-11-23
EP0430491B2 (en) 2000-10-25
EP0430491A3 (en) 1991-12-27
EP0430491B1 (en) 1994-06-08
BR9005908A (pt) 1991-09-24
DK0430491T3 (da) 1994-09-19

Similar Documents

Publication Publication Date Title
AR246186A1 (es) Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
DE69622574D1 (de) Zusammensetzung zur transdermalen wirkstoffabgabe
RU2386435C2 (ru) Не содержащая волокно чрескожная терапевтическая система и способ ее изготовления
ES2057080T3 (es) Sistema terapeutico transdermal empleando fisostigmina como componente activo, asi como procedimiento para su preparacion.
DK0674913T3 (da) Ikke-okklusivt klæbende plaster til påföring af medicament i huden
NO895171D0 (no) Fremgangsmaate for fremstilling av et transdermalt terapeutisk system med phytostigmin som virkestoff.
ES2032221T3 (es) Procedimiento para la obtencion de un sistema terapeutico transdermal multicapa.
DE10141652A1 (de) Transdermales therapeutisches System auf der Basis von Polyacrylat-Haftklebern ohne funktionelle Gruppen
ES2052210T3 (es) Pelicula compuesta para el tratamiento de superficies y procedimientos de fabricacion correspondientes.
ES2070401T3 (es) Preparacion para la administracion transdermica de farmacos.
ES2086353T3 (es) Sistema terapeutico percutaneo que contiene como componente activo buprenorfina.
ATE264098T1 (de) Pflaster zur transdermalen applikation von flüchtigen, flüssigen wirkstoffen
DK626484D0 (da) Systemer til afgivelse af virksomme stoffer
HRP930668A2 (en) Transdermal therapeutic adhesive plaster
BR9008012A (pt) Metodo e dispositivo para a liberacao de drogas para a pele
DE3485306D1 (de) Pharmazeutische zusammensetzung mit verzoegerter abgabe und verfahren zu deren herstellung.
HUP9903348A2 (hu) Transzdermális terápiás rendszer (tts) drogfüggőség vagy drogmegszokás kezelésére alkalmas hatóanyagok adagolására
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente
ES2045369T3 (es) Sistema terapeutico transdermico con norseudoefedrina como componente activo.
CO5640059A2 (es) Uso de clorofila para el control de malos olores en articulos absorbentes desechables
KR870007701A (ko) 불연속 패턴 접착층을 갖는 피부 및 경피용 패치